153 related articles for article (PubMed ID: 24096836)
1. Milnacipran inhibits itch-related responses in mice through the enhancement of noradrenergic transmission in the spinal cord.
Andoh T; Gotoh Y; Kuraishi Y
J Pharmacol Sci; 2013; 123(2):199-202. PubMed ID: 24096836
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic regulation of itch transmission in the spinal cord mediated by α-adrenoceptors.
Gotoh Y; Andoh T; Kuraishi Y
Neuropharmacology; 2011 Sep; 61(4):825-31. PubMed ID: 21664915
[TBL] [Abstract][Full Text] [Related]
3. Supraspinal Projection of Serotonergic and Noradrenergic Pathways Modulates Nociceptive Transmission in the Lower Urinary Tract of Rats.
Mitsui T; Kanno Y; Kitta T; Moriya K; Nonomura K
Low Urin Tract Symptoms; 2016 Sep; 8(3):186-90. PubMed ID: 27619785
[TBL] [Abstract][Full Text] [Related]
4. The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
Obata H; Saito S; Koizuka S; Nishikawa K; Goto F
Anesth Analg; 2005 May; 100(5):1406-1410. PubMed ID: 15845695
[TBL] [Abstract][Full Text] [Related]
5. The role of spinal serotonin receptor and alpha adrenoceptor on the antiallodynic effects induced by intrathecal milnacipran in chronic constriction injury rats.
Nakamura T; Ikeda T; Takeda R; Igawa K; Naono-Nakayama R; Sakoda S; Nishimori T; Ishida Y
Eur J Pharmacol; 2014 Sep; 738():57-65. PubMed ID: 24876059
[TBL] [Abstract][Full Text] [Related]
6. Effects of milnacipran, a 5-HT and noradrenaline reuptake inhibitor, on C-fibre-evoked field potentials in spinal long-term potentiation and neuropathic pain.
Ohnami S; Kato A; Ogawa K; Shinohara S; Ono H; Tanabe M
Br J Pharmacol; 2012 Oct; 167(3):537-47. PubMed ID: 22537101
[TBL] [Abstract][Full Text] [Related]
7. Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats.
Obata H; Kimura M; Nakajima K; Tobe M; Nishikawa K; Saito S
J Pharmacol Exp Ther; 2010 Sep; 334(3):1059-65. PubMed ID: 20558774
[TBL] [Abstract][Full Text] [Related]
8. Effects of the serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran on marble burying behavior in mice.
Sugimoto Y; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
Biol Pharm Bull; 2007 Dec; 30(12):2399-401. PubMed ID: 18057733
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and noradrenaline modulate chronic itch processing in mice.
Miyahara Y; Funahashi H; Naono-Nakayama R; Haruta-Tsukamoto A; Muroi C; Kogoh Y; Nishimori T; Ishida Y
Eur J Pharmacol; 2020 Sep; 883():173319. PubMed ID: 32619678
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems.
Tachibana K; Matsumoto M; Koseki H; Togashi H; Kojima T; Morimoto Y; Yoshioka M
J Psychopharmacol; 2006 Jul; 20(4):562-9. PubMed ID: 16401668
[TBL] [Abstract][Full Text] [Related]
11. Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and alpha 1-adrenoceptors.
Tachibana K; Matsumoto M; Togashi H; Kojima T; Morimoto Y; Kemmotsu O; Yoshioka M
Neurosci Lett; 2004 Mar; 357(2):91-4. PubMed ID: 15036582
[TBL] [Abstract][Full Text] [Related]
12. Milnacipran inhibits oxaliplatin-induced mechanical allodynia through spinal action in mice.
Andoh T; Kitamura R; Kuraishi Y
Biol Pharm Bull; 2015; 38(1):151-4. PubMed ID: 25744472
[TBL] [Abstract][Full Text] [Related]
13. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
Bandoh T; Hayashi M; Ino K; Takada S; Ushizawa D; Hoshi K
Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386
[TBL] [Abstract][Full Text] [Related]
14. Effect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats.
Kitaichi Y; Inoue T; Izumi T; Nakagawa S; Tanaka T; Masui T; Koyama T
Eur J Pharmacol; 2008 Apr; 584(2-3):285-90. PubMed ID: 18336812
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
[TBL] [Abstract][Full Text] [Related]
16. The antinociceptive effect of milnacipran in the monosodium iodoacetate model of osteoarthritis pain and its relation to changes in descending inhibition.
Burnham LJ; Dickenson AH
J Pharmacol Exp Ther; 2013 Mar; 344(3):696-707. PubMed ID: 23297162
[TBL] [Abstract][Full Text] [Related]
17. Preclinical pharmacology of milnacipran.
Briley M; Prost JF; Moret C
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():9-14. PubMed ID: 8923122
[TBL] [Abstract][Full Text] [Related]
18. Distinct effects of the serotonin-noradrenaline reuptake inhibitors milnacipran and venlafaxine on rat pineal monoamines.
Muneoka K; Kuwagata M; Ogawa T; Shioda S
Neuroreport; 2015 Jun; 26(9):510-4. PubMed ID: 26016648
[TBL] [Abstract][Full Text] [Related]
19. An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat.
Nakajima K; Obata H; Iriuchijima N; Saito S
Pain; 2012 May; 153(5):990-997. PubMed ID: 22424692
[TBL] [Abstract][Full Text] [Related]
20. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release.
Nagayasu K; Kitaichi M; Nishitani N; Asaoka N; Shirakawa H; Nakagawa T; Kaneko S
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2295-306. PubMed ID: 23920436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
